Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07450807) titled 'Prospective Randomized Controlled Pilot Study of Gut Microbiome Modulation by Nigella Sativa Seed Oil and Thymoquinone Metabolism in Healthy Volunteers' on March 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Aysun Tekbas
Condition:
Changes in Human Gut Microbiome in Healthy Adults
Intervention:
Dietary Supplement: Intake of Thymoquinone (TQ) containing Nigella Sativa Seed Oil (NSSO) capsules
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 2, ...